Chair of the Board · Prime Medicine, Inc. (PRME)

Jeffrey D. Marrazzo director compensation at Prime Medicine: $1.3M

Fiscal year 2025 director compensation for Jeffrey D. Marrazzo at Prime Medicine, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Jeffrey D. Marrazzo’s full pay file as a PDF — free

More than this page: up to 10 years of Jeffrey’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jeffrey D. Marrazzo and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Prime Medicine Director Compensation Table · all 3 fiscal years held
In US dollars, as Prime Medicine reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$45,000—$1,199,949$95,161$1,340,110
FY2024$44,125—$1,731,828$41,667$1,817,620
FY2023$30,199—$912,281—$942,480

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Prime Medicine, Inc. DEF 14A filed April 23, 2026, accession 0001628280-26-026697, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Prime Medicine, Inc. filed document, accession 0001628280-26-026697. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Get the Prime Medicine Board Governance Report

$1,340,110 Jeffrey D. Marrazzo, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Prime Medicine pays directors a $45,000 cash retainer.

The rest of the Prime Medicine board

FY2025 · as the company reported each
DirectorRoleFY2025 total
David Schenkein, M.DIndependent Director$196,424
Kaye FosterIndependent Director$222,359
Michael KellyIndependent Director$227,079
Robert NelsenIndependent Director$186,424
Thomas Cahill, M.D., Ph.DIndependent Director$193,924
Wendy Chung, M.D., Ph.DIndependent Director$222,079

The full Prime Medicine compensation record

free company brief

This page is one director within Prime Medicine's record. The company brief lists every named executive and director, each linking to their own page.

Order PRME

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report